Navigation Links
Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
Date:4/7/2009

- Initiation of a first-in-man Phase I clinical trial in healthy subjects

- Study aims to obtain safety and immunogenicity data of this new vaccine candidate

- Initial results expected in Q4 2009

- Development of Intercell's Streptococcus pneumoniae vaccine supported by PATH

VIENNA, April 7 /PRNewswire/ -- Intercell AG (VSE: ICLL) announced today that a Phase I clinical trial with the company's vaccine candidate IC47 to prevent disease caused by the bacterium Streptococcus pneumoniae has started.

Intercell's vaccine candidate is a recombinant subunit vaccine consisting of three conserved surface proteins from Streptococcus pneumoniae. Two of these proteins were discovered using Intercell's proprietary Antigen Identification Program (AIP(R)), while the third was in-licensed from the U.S. Centers of Disease Control and Prevention (CDC).

This Phase I trial is a first-in-man study with a focus to obtain safety and immunogenicity data in a small population of healthy adults. Thirty-two subjects will be enrolled in this open-label study. Two different vaccine concentrations either with or without the addition of an adjuvant will be tested.

"The initiation of this clinical Phase I trial is an important step to further strengthen Intercell's leading position in the development of vaccines against infectious diseases with significant unmet medical need," commented Intercell's Chief Scientific Officer, Alexander von Gabain.

Although vaccines against Streptococcus pneumoniae are available, they cover only a restricted number of the more than 90 known serotypes and it is essential to pursue new vaccines for distribution in countries with the highest medical need for an effective vaccine against the pathogen. Intercell's novel vaccine candidate is composed of highly conserved proteins of Streptococcus pneumoniae tha
'/>"/>

SOURCE Intercell AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
2. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
3. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
4. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
5. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
6. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
7. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
8. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
9. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
10. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
11. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... and MELVILLE, N.Y. , Nov. ... CAH ), one of the world,s largest health care ... HSIC ), the world,s largest provider of health care ... medical practitioners, today announced that the companies have entered ... the most comprehensive service and product offerings to office-based ...
(Date:11/21/2014)... 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ) announced ... will be presenting at the 26 th Annual Piper ... New York . The formal presentation is ... In addition, Mr. Krakauer and Jorgen B. Hansen , ... during the day. An audio webcast will ...
(Date:11/21/2014)...  The acceptance of two abstracts on the ... demonstrates continued interest in the Eclipse System, the ... of the abstracts, presented by Catherine Matthews ... Urogynecology and Reconstructive Pelvic Surgery at the University ... Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3
... Nov. 18 Starpharma Holdings Limited (ASX: SPL; OTCQX: ... of A$15.6 million through a private placement to institutional ... approximately A$24 million. , The lead investor in the ... highly regarded institutional fund manager. As a result ...
... , SAN DIEGO, Nov. 18 Rules-Based Medicine, Inc. ... and services agreement with Covance Inc. (NYSE: CVD ... powerful combination of biomarker technologies and services for use in ... RBM as its exclusive third-party provider of multiplexed protein biomarker ...
Cached Medicine Technology:Starpharma Announces $15.6 million Capital Raising 2Starpharma Announces $15.6 million Capital Raising 3Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 2Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. 3
(Date:11/22/2014)... Dylan Queen, a renowned brand in wedding dresses, has ... offers a wide range of special occasion dresses, shoes ... to create multiple looks easily. , According to the ... chic wedding dresses has been prepared for many months ... now. Dylan Queen can always create what ladies like, ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Nocturia ... as the complaint that the individual has to ... voiding. The report “Nocturia – Pipeline Review, H2 ... for Nocturia, complete with comparative analysis at various ... action (MoA), route of administration (RoA) and molecule ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 The topic ... complexity of block retaining walls. The article states that, “While ... are several necessary steps that go into creating this powerful ... building a retaining wall is choosing which kind of block ... , B&D Rockeries says, “The two main options are ...
(Date:11/22/2014)... November 22, 2014 Forbes Living ... are pleased to announce that Ashley Lombardo and friend ... contest. , Ms. Lombardo entered friend Candy Sherman ... She wrote of how her friend is courageously battling ... a single mom. Despite medical bills piling up and ...
(Date:11/22/2014)... “Greenfield Naturals” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... , From pollution to hazardous substances in water, harmful ... to remove these chemicals, especially in water. , A ...
Breaking Medicine News(10 mins):Health News:Dylan Queen Introduces Its New Wedding Dresses 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 2Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 3Health News:Nocturia Therapeutic Pipeline Market Review by Drugs and Companies H2 2014 Report at RnRMarketResearch.com 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2
... by many, because of its omega-3 fatty acids and, ... of farmed (mostly Atlantic salmon) and wild salmon fish// ... salmon, are contaminated with more environmental pollutants such as ... from Alaska. Many consumers have a choice between farm-raised ...
... hepatitis C virus infection is a bad prognostic ... renal transplant recipients//. ,Hepatitis C virus (HCV) infection ... the prevalence depends on the geographic area. Infections ... transplant recipients. ,Researchers from the Armed Forces ...
... British Indian psychiatrist apparently has plagiarised the work of ... his own in an article for a medical journal//. ... edition was written by Raj Persaud and went unnoticed ... Persaud is one of the youngest doctors to become ...
... Canadians are rushing to India and other Asian countries ... waiting//. ,According to a recent report, Canada is ... for three years for procedures such as knee replacement and ... now turning to the World Wide Web to find medical ...
... initiative for Center for Clinical Global Health Education was ... that improvement of medical care to patients would improve ... better way//, his initiative was to provide training by ... distance learning for healthcare providers. Bollinger said, “Don’t wait ...
... pre-eclampsia, the level of maternal serum leptin is increased ... TNF-á//. ,The research was conducted at University ... serum leptin concentration in women with pre-eclampsia and women ... leptin and several inflammatory cytokines. ,The study appears ...
Cached Medicine News:Health News:Indian Psychiatrist in UK Accused of plagiarism 2Health News:Indian Psychiatrist in UK Accused of plagiarism 3Health News:John Hopkins CGHH program provides Global Health education 2
Bookler Richardson Blade Set - for use with Bookler Universal Table Mounted Retractor Systems...
Richardson Retractors...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
Inquire...
Medicine Products: